Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

IEC WORKING GROUP WILL CONSIDER CHANGES TO EMC STANDARD FOR MEDICAL DEVICES AT HELSINKI MEETING; FDA's CONCERNS WITH PASS/FAIL CRITERIA TO BE ADDRESSED

This article was originally published in The Gray Sheet

Executive Summary

An International Electrotechnical Commission working group on electromagnetic compatibility will consider changes being sought by FDA to the IEC 601-1-2 safety standard at a meeting in Helsinki, Finland during the week of May 12.

You may also be interested in...



Revised IEC EMC Standard To Include More Stringent Pass/Fail Criteria - FDA

The International Electrotechnical Commission's revised 60601-1-2 electromagnetic compatibility (EMC) standard will include more rigorous immunity pass/fail criteria than the current version, according to Jeffrey Silberberg, senior electronics engineer in the Office of Science and Technology within the FDA Center for Devices and Radiological Health.

More Heartmate Troubles For Abbott. Latest Recall Includes 14 Deaths

Abbott initiated a recall in February of thousands of Heartmate devices due to a system obstruction that can result in serious health outcomes, including death. The FDA has now designated the recall as class I.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT008035

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel